TANG Capital Partners L.P., 10% Owner, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 192,308 shares at $26.00 ($5.0M) on 2018-03-29, disclosed to the SEC on 2018-04-02.
Open-market purchase of $5.0M HRTX by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |